NCT Number: NCT02081482
Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
The occipital nerve stimulation (ONS) is used to treat patients with refractory primary chronic headache but its mechanism of action (MoA) remains unknown. Different hypothesis have been suggested in particular a specific action on cerebral generators involved in different types of primary headaches or a non specific action on pain modulatory network.
The aim of this study, using the chronic cluster headache as a model, is to determine the changes in cerebral metabolism induced by ONS to precise its MoA in the treatment of primary chronic headache.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
CHU -Hôpital Gabriel Montpied, Clermont-Ferrand, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age > 18 years
- chronic cluster headache (according to the IHS)
- refractory in who a treatment by ONS have been indicated
- patient affiliated at social security,
- informed consent signed
Exclusion criteria
- contraindication to MRI
- contraindication to 18F-FDG PET
- women without contraception/pregnant/breast-feeding
- patient non-compliant
- patient on legal guardianship
Treatment and study plan
Primary outcomes
-
Comparison of cerebral metabolism
Time frame: Baseline (before ONS), 1 week after ONS , 3 month after ONS
Changes of cerebral metabolism associated with ONS efficacy
Sponsors and collaborators
Lead sponsor
Centre Hospitalier Universitaire de Nice
Other
Registry information
Official study title
Study of the Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
Acronym: MET-ONS
Important dates
- Study start
- 2014
- Primary completion
- 2015
- Study completion
- 2022
- First posted
- Mar 7, 2014
- Registry last updated
- Jun 16, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
NCT04814381
Brain Diseases, Central Nervous System Diseases
Annecy, France
View Trial DetailsRefractory Chronic Cluster Headache: Exploring the Potential of Repetitive Transcranial Magnetic Stimulation
NCT06917144
Brain Diseases, Central Nervous System Diseases
Madrid, Spain
View Trial DetailsOsteopathic Manual Therapy (OMT) and Brain Structure and Function in Primary Headache Patients: A Pilot Study
NCT06841627
Brain Diseases, Central Nervous System Diseases
Auburn, Alabama, United States
View Trial DetailsSphenopalatine Ganglion Pulsed Radiofrequency Treatment Outcomes
NCT07370142
Brain Diseases, Central Nervous System Diseases
Ankara, Turkey (Türkiye)
View Trial Details